More: IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
Visit link: Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine
Original post: Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care
Read the original: Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025
Visit link: Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29,...
Here is the original post: Renovaro Regains Compliance with NASDAQ Listing Requirement
Read more: Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old
Continue reading here: PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement
See the original post here: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
Recent Comments